SBIO

ALPS Funds$61.90+0.53 (+0.86%)
AUM $177.7MER 0.50%NAV $61.27Holdings 103

Price Chart

Key Statistics

Previous Close

$61.37

Day Range

$61.12$62.83

52-Week Range

$29.94$63.25

Avg Volume

29.1K

Dividend Yield

2.29%

Expense Ratio

0.50%

AUM

$177.7M

Shares Outstanding

2.9M

ETF Grades

?

Sector Breakdown

SectorWeight %
Healthcare100.00%

Country Allocation

CountryWeight %
United States88.31%
Canada3.19%
Netherlands2.17%
United Kingdom2.09%
Belgium1.49%
China1.24%
Germany0.82%
Singapore0.74%
Switzerland0.40%

Fund Information

Category
Healthcare
Inception Date
Dec 30, 2014
Exchange
NYSE_ARCA
Description
The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).

Similar ETFs

SymbolNameAUM
XLVState Street Health Care Select Sector SPDR ETF$39.60B
VHTVanguard Health Care ETF$19.00B
COWZPacer US Cash Cows 100 ETF$18.08B
XBIState Street SPDR S&P Biotech ETF$10.25B
RWLInvesco S&P 500 Revenue ETF$9.19B

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund issued by ALPS Funds that launched on Dec 30, 2014. It currently manages $177.7M in assets under management. The fund charges an expense ratio of 0.50%. The fund holds 103 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 30.3% of the fund

RankSymbolNameWeight %SharesMarket Value
1APGEApogee Therapeutics Inc.4.59%61,463$8.2M
2CGONCG oncology Inc.3.60%87,707$6.4M
3TVTXTravere Therapeutics Inc.3.07%92,387$5.5M
4XENEXenon Pharmaceuticals Inc.3.07%95,954$5.4M
5ORKAOruka Therapeutics Inc.2.92%59,980$5.2M
6DNTHDianthus Therapeutics Inc.2.80%54,345$5.0M
7MANEVeraDermics Inc.2.79%41,490$5.0M
8DFTXDefinium Therapeutics Inc2.74%108,520$4.9M
9EWTXEdgewise Therapeutics Inc.2.51%106,951$4.5M
10ACADACADIA Pharmaceuticals Inc.2.27%169,858$4.0M
11DNLIDenali Therapeutics Inc.2.19%157,660$3.9M
12RLAYRelay Therapeutics Inc.2.17%216,652$3.9M
13NAMSNewamsterdam Pharma Co. NV2.07%116,143$3.7M
14CRNXCrinetics Pharmaceuticals Inc.2.06%104,603$3.7M
15GPCRStructure Therapeutics Inc.1.92%70,615$3.4M
Page 1 of 3

Detailed Returns

PeriodReturnETF
1D
+0.86%
1W
+7.82%
1M
+16.68%
3M
+31.62%
6M
+23.25%
YTD
+26.10%
1Y
+108.41%
3Y
+103.34%
5Y
+27.39%

Moving Averages

20-Day MA

$54.40

Above 20-Day MA
50-Day MA

$54.47

Above 50-Day MA
200-Day MA

$49.27

Above 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$63.25

Current Price

$61.90

52-Week Low

$29.94

$29.94$63.25

Current Yield

2.29%

Annual Dividend

$1.2764

Frequency

1x/year

Last Ex-Date

Dec 19, 2024

Dividend History

Ex-DateAmountPay Date
Dec 19, 2024$1.1735Dec 26, 2024
Dec 21, 2023$0.0711Dec 27, 2023
Dec 19, 2019$0.0160Dec 27, 2019
Dec 19, 2019$0.0158Dec 27, 2019
Dec 20, 2018$0.7841Dec 27, 2018
Dec 20, 2018$0.7840Dec 27, 2018
Dec 21, 2017$0.5795Dec 28, 2017
Dec 21, 2017$0.5790Dec 28, 2017

Dividend Payments Over Time

Category Comparison

MetricSBIOHealthcare(175 ETFs)Healthcare(24 ETFs)
Fund Info
Expense Ratio0.50%0.62%0.48%
AUM$177.7M$945.4M$700.5M
Dividend Yield2.29%3.38%1.61%
Avg Volume29.1K290.1K105.9K
Holdings1039576
Performance
1-Month Return+25.20%+7.17%+5.84%
6-Month Return+24.24%+7.11%+4.53%
YTD Return+23.49%+9.12%+6.99%
1-Year Return+49.92%+16.01%+12.04%

Compare with Another ETF

Search for an ETF to compare with SBIO:

FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.